Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can ...

Larissa Banitt is a registered nurse who combines her English and Nursing degrees in writing health content. She has worked on the floor on a medical-surgical unit and currently works providing care ...

The EFFISAYIL ON study demonstrated that IV spesolimab may be an effective rescue therapy for GPP patients on SC spesolimab who experience a GPP flare.

Amgen's Tepezza became the first drug approved by the FDA for thyroid eye disease (TED) in 2020, and the company is now looking to extend its role with a new, more patient-friendly formulation. The ...

The Diabetes Control and Complications Trial (DCCT) recruited its first patients in 1983. In 1993, the investigators reported that intensive glycemic treatment of patients with type 1 diabetes ...